COVID virologic rebound may occur in patients treated with nirmatrelvir-ritonavir
1. In this retrospective cohort study, the virologic rebound (VR) of coronavirus disease 2019 (COVID-19) occurred far more frequently in ...
1. In this retrospective cohort study, the virologic rebound (VR) of coronavirus disease 2019 (COVID-19) occurred far more frequently in ...
1. In this retrospective cohort study, nirmatrelvir-ritonavir was effective in reducing 30-day hospitalization and mortality associated with coronavirus disease 2019 ...
1. In this retrospective cohort study, treatment with nirmatrelvir plus ritonavir was associated with a reduced risk of hospitalization within ...
1. Older adults treated with nirmatrelvir were significantly less likely to be hospitalized for coronavirus disease 2019 (COVID-19) than those ...
1. Older adults treated with nirmatrelvir were significantly less likely to be hospitalized for coronavirus disease 2019 (COVID-19) than those ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.